KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney International Supplements. 2021;11(2):1-274.
[2]
Alport AC. Hereditary familial congenital haemorrhagic nephritis. British Medical Journal. 1927;1(3456):504-506.
[3]
Fogo AB. Minimal change disease and focal segmental glomerulosclerosis. In: Alpers CE, ed. UpToDate. Wolters Kluwer; 2023.
[4]
Meyrier A. Genetics of focal segmental glomerulosclerosis. Kidney International. 2019;96(4):846-858.
[5]
Pollak MR. Inherited disorders of the glomerulus. In: Brenner BM, ed. Brenner & Rector's The Kidney. 11th ed. Elsevier; 2020.
[6]
Savige J, et al. Alport syndrome: clinical update. Kidney International Reports. 2020;5(6):759-768.
[7]
Wiggins RC. The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney International. 2007;71(12):1205-1214.
[8]
Hogg RJ, et al. National Kidney Foundation's Kidney Disease Outcomes Quality Initiative (KDOQI) commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney International. 2021;99(5):1065-1073.
[9]
Couser WG. Primary glomerulonephritis: mechanisms of glomerular injury. In: Johnson RJ, ed. Comprehensive Clinical Nephrology. 6th ed. Elsevier; 2019.
[10]
World Health Organization. ICD-10: International Statistical Classification of Diseases and Related Health Problems. 10th Revision. Geneva: WHO; 2019.